Key takeaways
Different decision-makers
ASCs are usually physician-owned. The surgeon, administrator, and materials manager are often three people in one room.
Different economics
ASC reimbursement is ~60% of HOPD. Implant cost-per-case has a much bigger impact on the facility's margin.
Different contracting
ASCs may belong to a chain (USPI, SCA, Surgery Partners) or be independent. GPO leverage and contract paths vary widely.
Different sales cycles
ASC trial-to-conversion can happen in weeks. Hospital VAC cycles take months. Plan inventory and time accordingly.
Why ASCs matter so much in 2026
CMS has steadily added procedures to the ASC-Covered Procedures List — total joints, complex spine, cardiology, and a growing slate of surgical specialties. Volumes that lived inside hospitals five years ago now move through ASCs, and the trend is accelerating.
- Total knee, total hip, and shoulder arthroplasty are increasingly ASC procedures.
- Spine cases (decompressions, single-level fusions) routinely run in ASCs.
- Cardiology PCIs and select EP procedures have begun migrating.
- ASC chains are consolidating — USPI, SCA, Surgery Partners, HCA Healthcare ASC, and independent physician-owned groups dominate.
Who you sell to
- ASC: physician-owners, medical director, administrator, materials manager. The ownership group meets monthly and decides quickly.
- Hospital: service-line chair, VAC, sourcing/contracting, OR director, finance. Multi-month cycles with multiple committees.
- ASC chain (USPI/SCA): regional sourcing leadership, corporate VAC, plus the local center buy-in. Both layers must agree.
- Hospital outpatient department (HOPD): often runs through hospital VAC even though the cost-of-care math looks more like an ASC.
Economics: where the math hurts
An ASC's entire P&L runs on tighter margins than a hospital. A $4,500 implant in a $7,000 ASC reimbursement bundle leaves very little room for facility overhead, staff, and profit distribution.
- ASC reimbursement is set by the ASC fee schedule, typically ~58–63% of HOPD rates.
- Many ASCs target a 50% implant-to-reimbursement ratio as a soft ceiling.
- Capped pricing, loaner-only programs, and consigned inventory are the norm.
- Hospitals can absorb implant cost via the DRG bundle plus pass-through codes; ASCs cannot.
Contracting paths
- Independent ASC: direct manufacturer agreement, often spot pricing or quarterly rebates.
- Physician-owned chain: corporate master agreement plus center-level approval.
- Hospital JV ASC: hospital sourcing dictates with input from physician partners.
- GPO contracts cover ASCs but are less binding than in hospitals; local price beats list almost always.
- Watch for vendor consolidation mandates from corporate parents (USPI/SCA standardization initiatives).
Case dynamics in the OR
- ASC turnover times are often half of hospital turnover. Reps who slow down a room get uninvited.
- Trays, instruments, and inventory are leaner — bring exactly what is needed, no more.
- Staff is smaller and cross-trained. Building trust with the circulator and tech is half the battle.
- Block schedules are tight; missing one case can cost you a quarter of monthly volume in that center.
What employers screen for
As volumes shift outpatient, employers want reps who can close ASC business — not just defend hospital share.
- Verified ASC accounts opened or grown (chains and independents).
- Comfort negotiating capped pricing and loaner programs.
- Ability to present to physician-owner partnership meetings.
- Examples of moving cases from hospital to ASC site of service successfully.
How MedSales Network helps
Reps with strong ASC track records are in extremely high demand. Surface those accounts, those wins, and the chains you've sold into so the right opportunities find you.
Show ASC experience clearly
Get matched to the device companies hiring for outpatient growth.